New updates on the understanding of the link between low-dose ionising radiation and mortality from haematological ...

Joseph Alvarnas, MD, of City of Hope, recaps yesterday's Institute for Value-Based Medicine® (IVBM) event on value-based oncology care, emphasizing patient-centered approaches and how attendees can ...

Advances in treatment and new drugs are pushing cancer care even farther away from hospital campuses into outpatient settings ...

The 21,000-square-foot new building, at 5490 Cobbler Way, replaces the cancer practice’s longtime western suburban facility ...

Sickle cell carriers are at a slightly increased risk of blood clots, but the overall risk is still low, a study found.

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, ...

Research presented at ESMO 2024 could have practice-changing implications for breast, gastrointestinal, genitourinary, and gynecologic cancers.

KUWAIT CITY, Sept 19: Kuwait’s Minister of Health, Dr. Ahmed Al-Awadhi, alongside Undersecretary Dr. Abdulrahman Al-Mutairi, ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with cancer want information and advice early in the ...

“For far too many children with cancer, clinical trials are their only chance at survival,” says Dr. Catherine Vézina. A ...